Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF

Author： Yamamoto Nobuto   Suyama Hirofumi   Nakazato Hiroaki   Yamamoto Nobuyuki   Koga Yoshihiko  

Publisher： Springer Publishing Company

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.57, Iss.7, 2008-07, pp. : 1007-1016

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Inhibitory effect of vitamin D-binding proteinderived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line

By            

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 685-691

Spandidos Publications

Access to resources Recommend Favorite

Vitamin D-binding protein gene polymorphisms and chronic obstructive pulmonary disease susceptibility: A meta-analysis

By  

Biomedical Reports, Vol. 3, Iss. 2, 2015-01 ,pp. : 183-188

Science Publishers

Access to resources Recommend Favorite

Epidemiology of Vitamin D and Colorectal Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 1, 2013-01 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy for Colorectal Cancer

By Boland Patrick M.   Ma Wen Wee  

Cancers, Vol. 9, Iss. 5, 2017-05 ,pp. : 50-50

MDPI

Access to resources Recommend Favorite

Immunotherapy in the Initial Treatment of Newly Diagnosed Cancer Patients: Utilization Trend and Cost Projections for Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, and Metastatic Colorectal Cancer

By Shih Ya-Chen Tina   Elting Linda S.   Pavluck Alexandre L.   Stewart Andrew   Halpern Michael T.  

Cancer Investigation, Vol. 28, Iss. 1, 2010-01 ,pp. : 46-53

Informa Healthcare

Access to resources Recommend Favorite